Heme oxygenase and ocular disease: a review of the literature.
Heme oxygenase (HO) catabolizes heme into three products: carbon monoxide (CO), biliverdin/bilirubin and free iron. Two distinct isoforms of HO have been identified: an inducible isozyme HO-1 and a constitutively expressed isozyme HO-2, which participate in a variety of physiological and pathophysiological processes. A growing body of evidence indicates that HO activation plays a variety of roles in several ocular diseases, functioning protectively by reducing oxidative injury, attenuating the inflammatory response, and inhibiting cell apoptosis. This review focuses on the current understanding of the physiological significance of HO and its putative roles in the ocular disease. Possible therapeutic strategies involving HO in the treatment of ocular disease are discussed.
Department of ophthalmology, Linyi People's Hospital, Linyi City, Shandong Province, China. sdlyzhaojun@tom.com
Jun
J
Zhao
Shaojian
S
Tan
Fangyi
F
Liu
Yingqiu
Y
Zhang
Mingshan
M
Su
Ding
D
Sun
D000818:Animals; D017209:Apoptosis; D019610:Cytoprotection / Q000502:physiology*; D005128:Eye Diseases / Q000201:enzymology* / Q000473:pathology; D006419:Heme Oxygenase (Decyclizing) / Q000502:physiology*; D006801:Humans
D006419:Heme Oxygenase (Decyclizing)